TARGETED THERAPY FOR PAPILLARY CRANIOPHARYNGIOMA


Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.
Nat Genet. 2014 Feb;46(2):161-5. 

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
J Natl Cancer Inst. 2015 Oct 23;108(2)

ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.
Eur J Endocrinol. 2016 Apr;174(4):R139-44.

Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
Neuro Oncol. 2018 Jul 5;20(8):1101-1112

Top